Camber (Camber)
Tolvaptan Tablet
Product Images NDC 31722-869
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tolvaptan (NDC 31722-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1.jpg (Figure 1)
The text is describing a medical report with details of the patient's electrolytes levels. The specific electrolyte mentioned is Sodium (Na+) and its concentration is +50 mEqL. The rest of the text seems to be irrelevant or not clear due to errors.*
Figure-2 (Figure 2)
Figure-3 (Figure 3)
This text indicates a measurement of mean serum sodium levels in a unit of mEq/L. The recorded values are 142 and 130.*
Tolvpcarton (Tolvpcarton)
This is a package label for Tolvaptan Tablets with NDC 31722-869-03. It contains 10 (1x10) Unit Dose Tablets, with each tablet containing 30 mg of Tolvaptan. The medication must be initiated in a hospital, and the usual dosage should be obtained from the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and a medical guide is available online. The manufacturing license number is 24/MD/TS/2016/F/G and the medication is manufactured for Camber Pharmaceuticals, Inc. in Piscataway, NJ 08854 by Annora Pharma Pit, Lt in Telangana, India. The remaining text seems to be product code and not relevant.*
Tolvpstructure (Tolvpstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
